Testing at Every Stage of Cancer Care
With over 450 specialized tests, including advanced genomic profiling,we help get you the answers you need to help more patients.
Featured Tests
From diagnosis to prognosis, treatment planning to post-treatment monitoring, our tests give youcomprehensive insights to deliver the best possible outcomes.
OmniSeq® INSIGHT
Comprehensive genomic and immune profiling gives a complete picture of the patient's tumor and details specific treatment options in one easy-to-interpret report
Labcorp® Plasma Focus™
A guideline-driven liquid biopsy test that targets 33 clinically actionable or relevant genes for optimal patient outcomes and treatment plan optimization in advanced solid tumors
IntelliGEN® Myeloid
A critical component of the heme work up providing diagnostic, prognostic, and therapy selection information for myeloid malignancies
PD-L1 immunohistochemistry (IHC)
Indicated in patients with specific tumor types in order to predict their responses to treatment with PD-L1 checkpoint inhibitors.
New Tests
Solid tumor: formalin-fixed, paraffin-embedded (FFPE) tissue blocks or slides; thyroid fine needle aspirate (FNA)
Leukemia: whole blood or bone marrow
Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides
Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides from NSCLC
Formalin-fixed, paraffin-embedded (FFPE) tissue or slides
One paraffin-embedded tumor and either whole blood or paraffin-embedded normal tissue